Glysolin R

Glysolin R




Cathay YSS


Concise Prescribing Info
Regular insulin, human (rDNA origin)
Type 1 diabetes. Type 2 diabetes who are not adequately controlled by diet &/or oral hypoglycemic agents. Initial stabilization of diabetes in patients w/ diabetic ketoacidosis, hyperosmolar non-ketotic syndrome & during period of stress eg, severe infections & major surgery in diabetic patients. Gestational diabetes.
Dosage/Direction for Use
Individualized dosage. Type 1 diabetes Maintenance: 0.5-1 IU/kg. Type 2 diabetes Approx 0.3-0.6 IU/kg/day. Administer SC in the abdominal wall, thigh, gluteal region or the deltoid region.
Should be taken with food: Inj should be followed w/in 30 min by a meal/snack containing carbohydrates.
Special Precautions
Renal & hepatic impairment. Switching to different type of insulin. Periodic measurement of glycosylated Hb for monitoring of long-term glycemic control. May affect ability to drive & use machines. Pregnancy & lactation.
Adverse Reactions
Hypoglycemia; edema; systemic & local allergy; lipoatrophy & lipodystrophy; acute & chronic insulin resistance.
Drug Interactions
Insulin requirements may be increased w/ hyperglycemic activity eg, corticosteroids, INH, certain lipid lowering drugs (eg, niacin), estrogens, OCs, phenothiazines & thyroid replacement therapy & may be decreased w/ hypoglycemic activity eg, oral hypoglycemic agents, salicylates, sulfa antibiotics, certain antidepressants (MAOIs, certain ACE inhibitors, β-adrenergic blockers, inhibitors of pancreatic function (eg, ocreotide) & alcohol. β-adrenergic blockers may mask the symptoms of hypoglycemia.
ATC Classification
A10AB01 - insulin (human) ; Belongs to the class of fast-acting insulins and analogues. Used in the treatment of diabetes.
Glysolin R 100 IU/mL soln for inj
10 mL x 1's (P609.84/vial)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in